Connect with:
Sunday, January 21, 2018
HomeHealthCeteraChoices for End Stage Kidney Disease

Choices for End Stage Kidney Disease


Over 100,000 people are diagnosed each year with End Stage Renal Disease (ESRD) and almost half a million people are living with it. The  progressive nature of the disease often eventually requires patients to go on kidney dialysis to survive, but the quality of life often deteriorates as patients spend multiple hours on each of several days every week hooked up to the dialysis machine. Despite this challenging course, only 10% of  patients with ESRD report having an end-of-life conversation with their nephrologist. The Coalition for Supportive Care of Kidney Patients is seeking to change this picture by having people with ESRD be fulling informed of their end-of-life options throughout the progression of the disease.


On April 20, 2017, HealthCetera Radio producer Diana Mason, PhD, RN, interviews two health professionals who are working with the Coalition on this aim through an initiative called My Way: Dale Lupu, MPH, PhD, Associate Research Professor with the Center for Aging, Health and Humanities at the George Washington University School of Nursing and Senior Adviser to the Coalition; and Liz Anderson, DSW, Assistant Professor of Social Work at Western Carolina University and Consultant/Palliative Care Expert for the Coalition. They discuss ESRD, advance directives, and a new brochure that’s available to help people with ESRD to make their end-of-life wishes known.

So tune in on Thursday, April 17th at 1:00 PM to WBAI, 99.5 FM in NYC or streaming at Or you can listen anytime by clicking here:


Written by

Diana is a co-director of the GW Nursing Center for Health Policy and Media Engagement and founder of HealthCetera. She was previously president of the American Academy of Nursing. She is senior policy professor at George Washington University and the Rudin Professor of Nursing at Hunter-Bellevue School of Nursing. She is a health policy expert and leader. Diana tweets @djmasonrn.

No comments

leave a comment